血管形的医疗治疗正在发展
Calver Pang1,2, Rebecca Lee3, Rebecca Nisbet1,4
1Department of Vascular Surgery, Royal Free London NHS Foundation Trust, London, UK.
Phlebology
|July 25, 2025
概括
血管形,异常的血管生长,已经限制了最佳治疗方法. 新兴的向疗法专注于PI3K/AKT/mTOR和RAS/RAF/MEK/ERK等分子途径,为有效的管理提供了新的希望.
科学领域:
- 血管生物学和医学
- 遗传学和分子信号传递
- 医学疗法医学疗法.
背景情况:
- 血管形是源于血管发育过程中的遗传突变引起的先天性异常.
- 目前的手术和栓塞等治疗方法都有局限性,包括并发症和不完全治愈.
- 了解分子病原发生对于开发先进疗法至关重要.
研究的目的:
- 审查不断发展的血管形治疗的医学疗法.
- 以突出基于分子信号通路的有针对性的治疗方法.
- 提供对新型治疗策略的概述.
主要方法:
- 对血管形的现有和新兴医学治疗方法的文献综述.
- 分析涉及病变发生的分子信号通路.
- 对有针对性的药物开发进行讨论.
主要成果:
- 针对PI3K/AKT/mTOR和RAS/RAF/MEK/ERK等关键途径正在开发有针对性的疗法.
- 诸如mTOR抑制剂,PIK3CA抑制剂,AKT抑制剂,MEK抑制剂和BRAF抑制剂等抑制剂显示出治疗潜力.
- 血管生成抑制剂也被认可用于治疗血管异常.
结论:
- 针对特定分子通路的新型医学疗法在治疗血管形方面取得了重大进展.
- 针对性治疗为传统的侵入性手术提供了一个有希望的替代方案.
- 对这些途径的进一步研究可能会产生更有效和个性化的治疗选择.
相关概念视频
Mitral Stenosis III: Medical Management
23
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
23
Aortic Regurgitation III: Medical Management
44
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
44
Aneurysm III: Interprofessional Care
26
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
26
Varicose Veins II: Diagnostic Studies and Interprofessional Care
31
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
31
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
225
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
225
Mitral Regurgitation III: Medical Management
31
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
31


